SCHEMBL797091

SCHEMBL797091

CCn1cc(/C=C(\C)[N+](=O)[O-])c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.50
KMT2A Q03164 8/20 0.50
MEN1 O00255 7/20 0.50
ALDH1A1 P00352 10/20 0.48
LMNA P02545 4/20 0.48
HPGD P15428 2/20 0.48
GAA P10253 2/20 0.48
POLB P06746 1/20 0.48
NPSR1 Q6W5P4 6/20 0.47
RAB9A P51151 2/20 0.47
HTT P42858 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
ATM Q13315 2/20 0.47
HSP90AA1 P07900 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
NR4A2 P43354 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL797092 1.00 MAPT (0.50) MAPTKMT2AMEN1ALDH1A1LMNA
SCHEMBL807793 1.00 MAPT (0.50) MAPTKMT2AMEN1ALDH1A1LMNA
SCHEMBL8416381 0.82 KMT2A (0.64) MAPTKMT2AMEN1ALDH1A1LMNA
SCHEMBL8416379 0.82 KMT2A (0.64) MAPTKMT2AMEN1ALDH1A1LMNA
SCHEMBL27683596 0.81 MAPT (0.48) MAPTKMT2AMEN1ALDH1A1LMNA
SCHEMBL8986616 0.79 ALDH1A1 (0.52) MAPTKMT2AMEN1ALDH1A1LMNA
SCHEMBL8758311 0.79 ALDH1A1 (0.52) MAPTKMT2AMEN1ALDH1A1LMNA
SCHEMBL797979 0.79 MAPT (0.72) MAPTKMT2AMEN1ALDH1A1LMNA
SCHEMBL797978 0.79 MAPT (0.72) MAPTKMT2AMEN1ALDH1A1LMNA
SCHEMBL31236298 0.79 MAPT (0.72) MAPTKMT2AMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627648-A1 17aHYDROXYLASE/C17,20-LYASE INHIBITORS Novartis AG (CH) 2013-08-21 EP disclosed
WO-2012035078-A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS NOVARTIS AG (CH) 2012-03-22 WO disclosed